After a retrial of part of its patent case against a larger competitor, Franklin-based catheter maker RyMed Technologies has triumphed with a new ruling.
In 2010 , after being sued by ICU Medical for infringing on three patents, RyMed was ruled to have violated two of the three. Subsequently, one of the patents in question has expired and the other infringement ruling was thrown out by a judge, who ordered a retrial.
Last week , a ruling was delivered in that retrial stating that RyMed has not, in fact, violated the patent in question.
“This is a major victory for RyMed,” said CEO Dana Ryan. “The jury’s decision proves that our claims about this case have been correct. It reinforces our ability to continue providing all of RyMed’s innovative technology to the market. In addition to providing a significant boost to our future business prospects, it also affirms our ongoing efforts to bring clinicians and patients the very best in IV catheter safety technology.”
As a result of the ruling, “ICU can no longer make any claim that RyMed’s products literally infringe on an in-force ICU Medical patent.”